multiple myeloma

News

AbbVie cuts $1.9bn+ deal with IGI for trispecific antibody

AbbVie has signed another deal in its effort to build an industry-leading position in multispecific antibodies for blood cancers.

News

Regeneron gets long-awaited FDA okay for myeloma drug

Regeneron's bid to join the crowded US market for BCMA-targeted bispecific antibodies for multiple myeloma has finally been realised.

Oncology

ASCO 2025: Building a stronger future in cancer care with a ...

From attending key oral sessions, clinical science symposiums and poster presentations to the simple pleasures of chatting with colleagues during coffee breaks, we left the

News

J&J says two drugs are better than one in pretreated myeloma

Combining Johnson & Johnson's multiple myeloma therapies Talvey and Tecvayli shows promise in a hard-to-treat form of multiple myeloma.

News

NHS starts first national rollout of Blenrep for myeloma

England is the first country in the world to make GSK's relaunched anti-BCMA drug Blenrep available to patients with multiple myeloma.

News

ASCO 25: Sanofi hopes on-body delivery will boost Sarclisa

Can a new on-body injector version of Sanofi's Sarclisa help it claim market share from J&J's rival top-selling Darzalex in multiple myeloma?

AbbVie cuts $1.9bn+ deal with IGI for trispecific antibody

Regeneron gets long-awaited FDA okay for myeloma drug

ASCO 2025: Building a stronger future in cancer care with a ...

J&J says two drugs are better than one in pretreated myeloma

NHS starts first national rollout of Blenrep for myeloma

ASCO 25: Sanofi hopes on-body delivery will boost Sarclisa

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

multiple myeloma

Editor's Picks